1.
Veelken K, Schönland S, Dittrich T, Kimmich C, Granzow M, Jauch A, Müller-Tidow C, Raab MS, Hegenbart U. Retrospective cohort study of treatment with BCL-2 inhibitor venetoclax in advanced AL amyloidosis. haematol [Internet]. 2020Sep.10 [cited 2026Jun.11];. Available from: https://haematologica.org/article/view/14223